Replimune Group, Inc. REPL
Set alert
17.61 USD +0.22 +1.27%
At close · Oct 30
17.53 -0.08 -0.45%
After hours · Oct 30, 7:30 PM ET
16.64 Day range 18.27
1.70 52-week range 17.61
- YTD
- +81.17%
- 1 year
- +71.80%
- Open
- 17.49
- Prev close
- 17.39
- Mkt cap
- 1.67B
- Vol
- 3.85M
- Avg vol
- 3.47M
- EPS
- -2.79
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.64
- High
- 18.27
- Forward P/E
- -27.19
- Beta
- 0.00
- Short ratio
- 11.50
- Inst. own
- 105.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 2, 2027
- 50-d avg
- 13.51
- 200-d avg
- 9.24
- 1y target
- 23.33
6M chart
Events in this range
- Jun 29, 2026Earnings: -0.76; estimate -0.73; surprise -4.11%
- Jul 31, 2026Rating: Wedbush · Neutral → Neutral
- Aug 4, 2026Rating: Leerink Partners · Market Perform → Outperform
- Aug 7, 2026Rating: Wedbush · Neutral → Outperform
- Aug 7, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 14, 2026Earnings: -0.72; estimate -0.694; surprise -3.75%
- Aug 26, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 28, 2026Earnings: -0.54; estimate -0.784; surprise 31.12%
- Oct 29, 2026Rating: Leerink Partners · Outperform → Outperform
Signals (31)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 3 days ago |
| RSI: Overbought | Oct 28, 2026 | 3 days ago |
| SMA: Bullish | Oct 26, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 26, 2026 | 5 days ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| RSI: Oversold | Jul 28, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| MACD: Sell Signal | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Jun 18, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| SMA: Bullish | May 29, 2026 | 5 months ago |
| RSI: Overbought | May 29, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 13, 2026 | 5 months ago |
Financial health
Altman Z-Score
-0.71 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.3×
FY 2017 5y median -3.2× FY 2026
P/S 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 4.3×
FY 2017 5y median 1.9× FY 2026
P/FCF -2.5×
FY 2017 5y median -3.9× FY 2026
EV/EBITDA -2.0×
FY 2017 5y median -2.9× FY 2026
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -40.1%
FY 2017 5y median -25.3% FY 2026
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -188.9%
FY 2017 5y median -57.6% FY 2026
ROIC -114.8%
FY 2017 5y median -52.0% FY 2026
ROA -94.4%
FY 2017 5y median -44.2% FY 2026
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2026
Operating Income -22.3%
FY 2017 FY 2026
EPS (diluted) -10.1%
FY 2017 FY 2026
Free Cash Flow -43.0%
FY 2017 FY 2026
Financial Health
Current Ratio 4.8×
FY 2017 5y median 10.7× FY 2026
Quick Ratio 4.8×
FY 2017 5y median 10.7× FY 2026
Debt / Equity 0.7×
FY 2017 5y median 0.2× FY 2026
Net Debt / EBITDA 0.3×
FY 2017 5y median 0.3× FY 2026
Interest Coverage -36.1×
FY 2017 5y median -36.1× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31